Sign in to view content

Suprachoroidal CLS-TA Plus Aflibercept Compared With Aflibercept Monotherapy for DME: Results of a Phase 2 Trial

Michael S. Ip, MD

Video
Published 2019

Michael S. Ip, MD

Diabetic Retinopathy Part I Symposium

Related

Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema
Chirag D. Jhaveri, MD, FASRS
Updates from the Field
2022
Diabetic Retinopathy and the MyVisionTrack App Study (DRAMA)
Samuel K. Steven Houston, MD, FASRS
On Demand Cases, Courses, and Papers
2017
Loss to Follow-up in Patients With Proliferative Diabetic Retinopathy Treated With Anti-VEGF Therapy and/or PRP in the United States
Rahul N. Khurana, MD, FASRS
Annual Meeting Talks
2021

Category: Diabetic Retinopathy

See more